ArticleWorld journal of diabetes2024
Dapagliflozin in heart failure and type 2 diabetes: Efficacy, cardiac and renal effects, safety.
Pei-Ling Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it